Electromed, Inc.
Financial highlights
| Metric | FY 06/30/25 | FY 06/30/24 | FY 06/30/23 | FY 06/30/22 | FY 06/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $64.0M | $54.7M | $48.1M | $41.7M | $35.8M |
| Cost of revenue | $14.0M | $13.0M | $11.5M | $10.2M | $8.5M |
| Gross profit | $50.0M | $41.7M | $36.5M | $31.4M | $27.3M |
| Selling, general & administrative | $39.3M | $34.5M | $31.6M | $27.1M | $22.4M |
| Research and development | $996,000 | $656,000 | $916,000 | $1.4M | $1.7M |
| Operating expenses | $40.3M | $35.1M | $32.5M | $28.5M | $24.2M |
| Operating income | $9.7M | $6.6M | $4.0M | $3.0M | $3.1M |
| Pretax income | $10.3M | $7.0M | $4.1M | $3.0M | $3.2M |
| Income tax expense | $2.7M | $1.9M | $920,000 | $692,000 | $805,000 |
| Net income | $7.5M | $5.2M | $3.2M | $2.3M | $2.4M |
| Balance Sheet | |||||
| Cash and equivalents | $15.3M | $16.1M | $7.4M | $8.2M | $11.9M |
| Current assets | $45.1M | $44.2M | $37.8M | $34.5M | $31.7M |
| Total assets | $53.8M | $52.2M | $45.8M | $41.4M | $37.1M |
| Current liabilities | $10.5M | $7.7M | $8.1M | $7.2M | $4.6M |
| Total liabilities | $10.6M | $7.7M | $8.1M | $7.2M | $4.7M |
| Stockholders' equity | $43.2M | $44.5M | $37.7M | $34.2M | $32.4M |
| Cash Flow Statement | |||||
| Cash from operations | $11.4M | $9.1M | $1.3M | -$686,000 | $3.1M |
| Depreciation and amortization | $1.0M | $789,000 | $550,000 | $503,000 | $477,000 |
| Stock-based compensation | $3.1M | $1.7M | $708,000 | $976,000 | $1.0M |
| Capital expenditure | $262,000 | $287,000 | $1.6M | $1.4M | $287,000 |
| Free cash flow | $11.1M | $8.8M | -$333,000 | -$2.1M | $2.8M |
| Share repurchases | $10.0M | $275,000 | $153,000 | $1.4M | $1.1M |
| Impairments | $212,000 | $0 | — | — | — |
Shares outstanding 8.3M · Free float 70.2%
Annual filing data through FY ended June 30, 2025; float as of July 13, 2026.